Efficacy and safety of a clinical protocol for expectant management of selected women diagnosed with a tubal ectopic pregnancy
- PMID: 23303651
- DOI: 10.1002/uog.12401
Efficacy and safety of a clinical protocol for expectant management of selected women diagnosed with a tubal ectopic pregnancy
Abstract
Objective: To validate the efficacy and safety of our clinical protocol for expectant management of selected women diagnosed with tubal ectopic pregnancy.
Methods: This was a prospective observational study carried out in the early pregnancy unit of a London inner-city university teaching hospital from 1(st) January 2008 to 31(st) May 2011. All women presenting with suspected early pregnancy complications were assessed clinically and by transvaginal ultrasound. Those with a conclusive ultrasound diagnosis of tubal ectopic pregnancy were selected for either surgical or expectant management. Selection criteria for expectant management were clinical stability with no or minimal abdominal pain, no evidence of significant hemoperitoneum on ultrasound scan, ectopic pregnancy measuring < 30 mm in mean diameter with no evidence of embryonic cardiac activity, serum β-human chorionic gonadotropin (β-hCG) < 1500 IU/L and the woman's consent. All women selected for expectant management were followed up as outpatients until the ectopic pregnancy regressed spontaneously (resolution of clinical symptoms, serum β-hCG < 20 IU/L/negative urine pregnancy test) or surgical intervention was required. We recorded the rate of interventions, complications and length of follow-up.
Results: During the study period 339/11 520 (2.9% (95% CI, 2.59-3.21%)) women were diagnosed with tubal ectopic pregnancy. Six women opted to participate in an ongoing randomized controlled trial and were excluded from further analysis. One hundred and sixty-five (49.5% (95% CI, 44.2-55.0%)) of the 333 remaining women met the criteria for expectant management; 146/333 (43.8% (95% CI, 38.5-49.1%)) of them opted for expectant management and 104/333 (31.2% (95% CI, 26.2-36.2%)) of all tubal ectopics resolved without requiring any intervention. All women with failed expectant management were treated by laparoscopic salpingectomy/salpingotomy and none of them required a blood transfusion.
Conclusion: Our clinical protocol for expectant management of tubal ectopic pregnancies eliminates the need for medical or surgical treatment in more than a third of women diagnosed with tubal ectopic pregnancy with a minimum risk of adverse outcome.
Copyright © 2013 ISUOG. Published by John Wiley & Sons, Ltd.
Similar articles
-
Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysis.Ultrasound Obstet Gynecol. 2004 Jun;23(6):552-6. doi: 10.1002/uog.1061. Ultrasound Obstet Gynecol. 2004. PMID: 15170794
-
β-hCG resolution times during expectant management of tubal ectopic pregnancies.BMC Womens Health. 2015 May 21;15:43. doi: 10.1186/s12905-015-0200-7. BMC Womens Health. 2015. PMID: 25994203 Free PMC article.
-
Serum Human Chorionic Gonadotropin (β- hCG) Clearance Curves in Women with Successfully Expectantly Managed Tubal Ectopic Pregnancies: A Retrospective Cohort Study.PLoS One. 2015 Jul 2;10(7):e0130598. doi: 10.1371/journal.pone.0130598. eCollection 2015. PLoS One. 2015. PMID: 26135923 Free PMC article.
-
Clinical diagnosis and treatment of ectopic pregnancy.Obstet Gynecol Surv. 2013 Aug;68(8):571-81. doi: 10.1097/OGX.0b013e31829cdbeb. Obstet Gynecol Surv. 2013. PMID: 23921671 Review.
-
Diagnosis and management of ectopic pregnancy.Am Fam Physician. 2005 Nov 1;72(9):1707-14. Am Fam Physician. 2005. PMID: 16300032 Review.
Cited by
-
Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies.Reprod Biol Endocrinol. 2015 Apr 12;13:30. doi: 10.1186/s12958-015-0025-0. Reprod Biol Endocrinol. 2015. PMID: 25884617 Free PMC article. Review.
-
Predictive values of the ratio of beta-human chorionic gonadotropin for failure of salpingostomy in ectopic pregnancy.Int J Clin Exp Pathol. 2019 Mar 1;12(3):901-908. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933899 Free PMC article.
-
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.BMJ Open. 2013 Jul 19;3(7):e002902. doi: 10.1136/bmjopen-2013-002902. Print 2013. BMJ Open. 2013. PMID: 23872290 Free PMC article.
-
Expectant management versus systemic methotrexate in the management of persistent pregnancy of unknown location, a seven-year retrospective analysis.Arch Gynecol Obstet. 2024 Mar;309(3):1035-1041. doi: 10.1007/s00404-023-07332-x. Epub 2024 Jan 9. Arch Gynecol Obstet. 2024. PMID: 38194091
-
Interpregnancy interval and risk of recurrence following tubal ectopic pregnancy: retrospective cohort study from UK tertiary center.Ultrasound Obstet Gynecol. 2025 Jul;66(1):89-95. doi: 10.1002/uog.29262. Epub 2025 Jun 5. Ultrasound Obstet Gynecol. 2025. PMID: 40472183 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous